what phase is retatrutide in Eli Lilly just announced striking 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide produces up to 30.3%

The complete comparison table Seeing all the data side by side makes the differences clearer

Brain struct Funct 226(1):225245 Xie Z, Enkhjargal B, Wu L, Zhou K, Sun C, Hu X, Gospodarev V, Tang J, You C, Zhang JH (2018) Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats

When people try to work out on extremely low calories, protein shakes alone, or a near-zero-carb intake that does not match their activity, performance often suffers

Rosselin G, Leclercq-Meyer V, Boissart C et al

The launch comes amid the rapid rise of GLP-1 therapies for diabetes and weight management, which are transforming treatment approaches in India and globally